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. Onychodystrophy of the patient.
The gastric and sigmoid-colic biopsies reveal cystic and tortuous dilation of the glands of the gastric mucosa, coated with a well-differentiated and non-dysplastic single stratified epithelium ( Fig. 3a-c) . The glands are irregularly dispersed in an abundant, focally haemorrhagic chorion, consisting of a polymorphous inflammatory infiltrate of lymphoplasmocytary predominance (Fig. 3d ). The patient also underwent a colon-MRI and CT enteroclysis that found multiple polyps along the entire gastric antrum and the large intestine, with more severe impairment of the sigmoid ( Fig. 4a-d) . A doubt remained as to the impairment of the small intestine by CT enteroclysis, although the endoscopic videocapsule carried out as a complement found a jejeunum and ileum with a healthy mucosa, free of any polyps. The manifestations of the integuments (partial alopecia and onychotrophia), associated with gastric polyposis, support the diagnosis of Cronkhite-Canada syndrome raised during the anatomopathology examination. An initial treatment by intestinal anti-inflammatory consisting of 5-aminosalicylic acid derivatives (5-ASA) was found to be ineffective. A trial treatment with corticoids and nutritional measures was initiated and improved the clinical symptomatology in two months. The patient was informed of the possibility of a colectomy in case of clinical aggravation or inefficacy of the drug treatments.
Discussion
Cronkhite-Canada syndrome is a rare disorder of unknown pathogenesis. It was described in 1955 by Leonard Wolsey Cronkhite Jr, an internist and Wilma Jeanne Canada, a radiologist [1] . This syndrome associates non-hereditary gastrointestinal polyposis, onychotrophia, alopecia and skin hyperpigmentation. The incidence is estimated at 1/1,000,000 with 400 cases described in the world, 75% of which are in Japan [2] . The mean age of the diagnosis is 59 years [3] . The clinical picture is dominated by abundant diarrhoea, protein-losing enteropathy, frequently responsible for severe undernutrition and hydroelectric disorders that condition the prognosis of this disease. The 5-year rate of survival is 55%.
Polyposis is characterised by sessile, red, raspberry-like polyps of variable size that affect the entire digestive tube except for the oesophagus. Initially described as adenomateous polyps [1] , in reality the lesions correspond to hamartomateous juvenile polyps. The histological examination shows a preserved surface epithelium, cystic proliferation and dilation of the glands of the mucous membrane enclosing mucus. The chorion is inflammatory, abundant and encloses a polymorphous cell infiltrate. Cases of cancerous degeneration have been reported although the origin is not certain since, classically, juvenile polyps do not degenerate [4, 5] . The hypothesis of cancerisation of co-existant adenomateous polyps is most likely. Therefore, regular annual endoscopic monitoring is recommended [3] . Juvenile polyposis and the Peutz-Jeghers syndrome are the main differential diagnoses [6] . Given the rarity of this disorder, the treatment has not been clearly established. Dietetic measures and corticoid treatment are usually proposed. The duration varies according to the clinical response [3] . Surgical treatment by subtotal gastrectomy or colectomy is reserved for the complicated forms (gastric occlusion, cancer) or forms resistant to medical treatment due to its high morbidity. 
